Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Latest, Q2 2026
5,104
Period ended Jun 30, 2026
Change on a year earlier
-26.6%
6,951 in Q2 2025
History
75 quarters
Since Q4 2006
Sources
63
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash & Cash Equivalents ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 5,104 | -26.6% | Form 10-Q (filed 2026-07-28) ↗ |
| Q1 2026 | Mar 31, 2026 | 6,803 | +4.1% | Form 10-Q (filed 2026-04-29) ↗ |
| Q4 2025 | Dec 31, 2025 | 8,522 | +11.9% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2025 | Sep 30, 2025 | 7,511 | -0.6% | Form 10-Q (filed 2025-10-29) ↗ |
| Q2 2025 | Jun 30, 2025 | 6,951 | -0.5% | Form 10-Q (filed 2025-07-30) ↗ |
| Q1 2025 | Mar 31, 2025 | 6,532 | +3.9% | Form 10-Q (filed 2025-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | 7,616 | +10.4% | Form 10-K (filed 2025-02-21) ↗ |
| Q3 2024 | Sep 30, 2024 | 7,558 | +12.7% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 6,987 | -10.8% | Form 10-Q (filed 2024-07-31) ↗ |
| Q1 2024 | Mar 31, 2024 | 6,284 | -31.4% | Form 10-Q (filed 2024-05-02) ↗ |
| Q4 2023 | Dec 31, 2023 | 6,896 | -30.2% | Form 10-K (filed 2024-02-16) ↗ |
| Q3 2023 | Sep 30, 2023 | 6,709 | -30.1% | Form 10-Q (filed 2023-11-01) ↗ |
| Q2 2023 | Jun 30, 2023 | 7,835 | -12.3% | Form 10-Q (filed 2023-08-03) ↗ |
| Q1 2023 | Mar 31, 2023 | 9,161 | +19.4% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2022 | Dec 31, 2022 | 9,882 | +0.8% | Form 10-K (filed 2023-02-17) ↗ |
| Q3 2022 | Sep 30, 2022 | 9,594 | +3.1% | Form 10-Q (filed 2022-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | 8,937 | +3.2% | Form 10-Q (filed 2022-08-02) ↗ |
| Q1 2022 | Mar 31, 2022 | 7,675 | -4.7% | Form 10-Q (filed 2022-05-03) ↗ |
| Q4 2021 | Dec 31, 2021 | 9,799 | +43.3% | Form 10-K (filed 2022-02-18) ↗ |
| Q3 2021 | Sep 30, 2021 | 9,302 | +107.6% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 8,658 | +81.8% | Form 10-Q (filed 2021-08-04) ↗ |
| Q1 2021 | Mar 31, 2021 | 8,054 | +138.5% | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 6,838 | +77.2% | Form 10-K (filed 2021-02-19) ↗ |
| Q3 2020 | Sep 30, 2020 | 4,480 | +9.5% | Form 10-Q (filed 2020-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 4,763 | +51.8% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | 3,377 | +11.7% | Form 10-Q (filed 2020-04-29) ↗ |
| Q4 2019 | Dec 31, 2019 | 3,860 | +0.4% | Form 10-K (filed 2020-02-21) ↗ |
| Q3 2019 | Sep 30, 2019 | 4,091 | -44.5% | Form 10-Q (filed 2019-10-31) ↗ |
| Q2 2019 | Jun 30, 2019 | 3,137 | +2.3% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | 3,022 | -21.6% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 3,844 | -59.1% | Form 10-K (filed 2019-02-22) ↗ |
| Q3 2018 | Sep 30, 2018 | 7,369 | -33.1% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | 3,065 | -68.3% | Form 10-Q (filed 2018-08-01) ↗ |
| Q1 2018 | Mar 31, 2018 | 3,857 | -55.7% | Form 10-Q (filed 2018-05-02) ↗ |
| Q4 2017 | Dec 31, 2017 | 9,407 | -49.5% | Form 10-K (filed 2018-02-16) ↗ |
| Q3 2017 | Sep 30, 2017 | 11,012 | +340.5% | Form 10-Q (filed 2017-11-02) ↗ |
| Q2 2017 | Jun 30, 2017 | 9,675 | +275.3% | Form 10-Q (filed 2017-08-02) ↗ |
| Q1 2017 | Mar 31, 2017 | 8,706 | +161.1% | Form 10-Q (filed 2017-05-03) ↗ |
| Q4 2016 | Dec 31, 2016 | 18,620 | +272.3% | Form 10-K (filed 2017-02-17) ↗ |
| Q3 2016 | Sep 30, 2016 | 2,500 | -20.2% | Form 10-Q (filed 2016-11-03) ↗ |
| Q2 2016 | Jun 30, 2016 | 2,578 | -36.3% | Form 10-Q (filed 2016-08-03) ↗ |
| Q1 2016 | Mar 31, 2016 | 3,334 | +3.3% | Form 10-Q (filed 2016-05-04) ↗ |
| Q4 2015 | Dec 31, 2015 | 5,001 | +23.1% | Form 10-K (filed 2016-02-19) ↗ |
| Q3 2015 | Sep 30, 2015 | 3,132 | -13.3% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 4,048 | +13.4% | Form 10-Q (filed 2015-08-04) ↗ |
| Q1 2015 | Mar 31, 2015 | 3,226 | +56.6% | Form 10-Q (filed 2015-05-06) ↗ |
| Q4 2014 | Dec 31, 2014 | 4,063 | +16.9% | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2014 | Sep 30, 2014 | 3,613 | +25.4% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2014 | Jun 30, 2014 | 3,570 | -35.9% | Form 10-Q (filed 2014-08-05) ↗ |
| Q1 2014 | Mar 31, 2014 | 2,060 | -52.9% | Form 10-Q (filed 2014-05-07) ↗ |
| Q4 2013 | Dec 31, 2013 | 3,475 | -67.8% | Form 10-K (filed 2014-02-21) ↗ |
| Q3 2013 | Sep 30, 2013 | 2,882 | -64.0% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2013 | Jun 30, 2013 | 5,572 | -21.0% | Form 10-Q (filed 2014-08-05) ↗ |
| Q1 2013 | Mar 31, 2013 | 4,373 | +0.6% | Form 10-Q (filed 2014-05-07) ↗ |
| Q4 2012 | Dec 31, 2012 | 10,802 | +58.5% | Form 10-K (filed 2014-02-21) ↗ |
| Q3 2012 | Sep 30, 2012 | 7,997 | +58.4% | Form 10-Q (filed 2012-11-07) ↗ |
| Q2 2012 | Jun 30, 2012 | 7,053 | +73.0% | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | 4,346 | +58.6% | Form 10-Q (filed 2012-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | 6,813 | +86.8% | Form 10-K (filed 2014-02-21) ↗ |
| Q3 2011 | Sep 30, 2011 | 5,049 | +32.2% | Form 10-Q (filed 2011-11-04) ↗ |
| Q2 2011 | Jun 30, 2011 | 4,077 | -5.7% | Form 10-Q (filed 2011-08-04) ↗ |
| Q1 2011 | Mar 31, 2011 | 2,740 | +74.9% | Form 10-Q (filed 2011-05-06) ↗ |
| Q4 2010 | Dec 31, 2010 | 3,648 | -58.6% | Form 10-K (filed 2014-02-21) ↗ |
| Q3 2010 | Sep 30, 2010 | 3,818 | -21.7% | Form 10-Q (filed 2010-11-05) ↗ |
| Q2 2010 | Jun 30, 2010 | 4,322 | +2.8% | Form 10-Q (filed 2010-08-05) ↗ |
| Q1 2010 | Mar 31, 2010 | 1,567 | -67.9% | Form 10-Q (filed 2010-05-04) ↗ |
| Q4 2009 | Dec 31, 2009 | 8,809 | +114.2% | Form 10-K (filed 2010-02-19) ↗ |
| Q3 2009 | Sep 30, 2009 | 4,876 | +73.5% | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2009 | Jun 30, 2009 | 4,204 | +10.7% | Form 10-Q (filed 2009-08-07) ↗ |
| Q1 2009 | Mar 31, 2009 | 4,875 | – | Form 10-Q (filed 2010-05-04) ↗ |
| Q4 2008 | Dec 31, 2008 | 4,112 | +67.4% | Form 10-Q (filed 2009-08-07) ↗ |
| Q3 2008 | Sep 30, 2008 | 2,810 | – | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2008 | Jun 30, 2008 | 3,797 | – | Form 10-Q (filed 2009-08-07) ↗ |
| Q4 2007 | Dec 31, 2007 | 2,456 | +371.4% | Form 10-Q (filed 2009-08-07) ↗ |
| Q4 2006 | Dec 31, 2006 | 521 | – | Form 10-K (filed 2010-02-19) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Cash & Cash Equivalents ($M) ($M), quarterly Q4 2006–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-bs-cash
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.